Amgen Inc
AMGN Real Time Price USD$AMGN stock is featured in our Top Lobbying Spenders, Dan Meuser, and Sheldon Whitehouse strategies.
See All StrategiesRecent trades of AMGN by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by AMGN's directors and management
Government lobbying spending instances
-
$15,000 Oct 21, 2024 Issue: Health Issues
-
$60,000 Oct 21, 2024 Issue: Health Issues
-
$2,770,000 Oct 21, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$60,000 Oct 21, 2024 Issue: Immigration Medicare/Medicaid Health Issues
-
$60,000 Oct 21, 2024 Issue: Pharmacy Medicare/Medicaid
-
$50,000 Oct 21, 2024 Issue: Medicare/Medicaid
-
$50,000 Oct 21, 2024 Issue: Health Issues
-
$80,000 Oct 20, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Oct 19, 2024 Issue: Health Issues
-
$60,000 Oct 18, 2024 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$60,000 Oct 18, 2024 Issue: Law Enforcement/Crime/Criminal Justice Copyright/Patent/Trademark Labor Issues/Antitrust/Workplace Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$7,500 Oct 17, 2024 Issue: Health Issues
-
$60,000 Oct 15, 2024 Issue: Medicare/Medicaid
-
$30,000 Oct 14, 2024 Issue: Health Issues
-
$50,000 Oct 13, 2024 Issue: Medicare/Medicaid
-
$60,000 Jul 22, 2024 Issue: Immigration Medicare/Medicaid Health Issues
-
$2,740,000 Jul 22, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$60,000 Jul 22, 2024 Issue: Pharmacy Medicare/Medicaid
-
$60,000 Jul 22, 2024 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$50,000 Jul 22, 2024 Issue: Health Issues
-
$50,000 Jul 20, 2024 Issue: Health Issues
-
$50,000 Jul 19, 2024 Issue: Medicare/Medicaid
-
$5,000 Jul 19, 2024 Issue: Health Issues
-
$80,000 Jul 19, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$90,000 Jul 19, 2024 Issue: None
-
$7,500 Jul 15, 2024 Issue: Health Issues
-
$60,000 Jul 15, 2024 Issue: Medicare/Medicaid
-
$30,000 Jul 15, 2024 Issue: Health Issues
-
$60,000 Apr 22, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$60,000 Apr 22, 2024 Issue: Immigration Medicare/Medicaid Health Issues
-
$7,500 Apr 22, 2024 Issue: Health Issues
-
$60,000 Apr 22, 2024 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$50,000 Apr 22, 2024 Issue: Health Issues
-
$50,000 Apr 21, 2024 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2024 Issue: Health Issues
-
$90,000 Apr 19, 2024 Issue: None
-
$3,330,000 Apr 19, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$30,000 Apr 12, 2024 Issue: Health Issues
-
$60,000 Apr 12, 2024 Issue: Medicare/Medicaid
-
$60,000 Feb 07, 2024 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$60,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Jan 22, 2024 Issue: Medicare/Medicaid
-
$60,000 Jan 22, 2024 Issue: None
-
$50,000 Jan 22, 2024 Issue: Health Issues
-
$3,550,000 Jan 19, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$60,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$60,000 Oct 20, 2023 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$50,000 Oct 20, 2023 Issue: Health Issues
-
$2,240,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Oct 19, 2023 Issue: Medicare/Medicaid
-
$50,000 Oct 19, 2023 Issue: Health Issues
-
$60,000 Oct 16, 2023 Issue: Health Issues Medicare/Medicaid
-
$2,140,000 Oct 16, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$1,950,000 Jul 21, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2023 Issue: Health Issues
-
$60,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Jul 19, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$50,000 Jul 19, 2023 Issue: Health Issues
-
$60,000 Jul 18, 2023 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues
-
$60,000 Jul 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
-
$60,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Health Issues
-
$80,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Jan 19, 2023 Issue: Health Issues
-
$80,000 Jan 14, 2023 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
-
$80,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$50,000 Oct 20, 2022 Issue: Health Issues
-
$50,000 Oct 19, 2022 Issue: Health Issues
-
$3,150,000 Oct 18, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$80,000 Oct 16, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
-
$60,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$2,200,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,410,000 Jul 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2022 Issue: Health Issues
-
$80,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Jul 19, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$50,000 Jul 19, 2022 Issue: Health Issues
-
$80,000 Jul 15, 2022 Issue: Communications/Broadcasting/Radio/TV Health Issues Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$2,780,000 Apr 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Apr 20, 2022 Issue: Health Issues
-
$80,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2022 Issue: Health Issues
-
$80,000 Apr 15, 2022 Issue: Health Issues Medicare/Medicaid
-
$70,000 Jan 21, 2022 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$2,410,000 Jan 20, 2022 Issue: None
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$80,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2022 Issue: Health Issues
-
$80,000 Jan 18, 2022 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$80,000 Jan 15, 2022 Issue: None
-
$70,000 Oct 20, 2021 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$2,620,000 Oct 20, 2021 Issue: None
-
$80,000 Oct 20, 2021 Issue: Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 18, 2021 Issue: Health Issues
-
$80,000 Oct 18, 2021 Issue: None
Estimated quarterly lobbying spending
New patents grants
No new patents for this ticker
U.S. Patents DashboardFederal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of AMGN in WallStreetBets Daily Discussion
Recent insights relating to AMGN
Recent picks made for AMGN stock on CNBC
ETFs with the largest estimated holdings in AMGN
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AMGN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.